Seroprevalence of Hepatitis B and C among HIV-Positive Adults on Antiretroviral Therapy in a Rural District of Western Tanzania

Read full text Summarise with VIRAT
Authors: Getera Isack Nyangi
Cited by: 0
References: 17

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Hepatitis B virus (HBV) and hepatitis C virus (HCV) co-infections are important causes of morbidity and mortality among people living with HIV (PLHIV), particularly in sub-Saharan Africa. Although several studies have documented the burden of HIV–hepatitis co-infection in urban and peri-urban settings in Tanzania, data from rural western regions remain limited. This study aimed to determine the seroprevalence of HBV and HCV among HIV-positive adults receiving antiretroviral therapy (ART) in Kakonko District, western Tanzania. A facility-based cross-sectional study was conducted among HIV-positive adults aged ≥ 18 years attending three Care and Treatment Clinics in Kakonko District. Participants were selected using simple random sampling. Sociodemographic and clinical data were collected using a structured questionnaire. Finger-prick blood samples were tested for hepatitis B surface antigen (HBsAg) and anti-HCV antibodies using rapid immunochromatographic assays. Data were analyzed using Stata version 16, and seroprevalence was calculated with 95% confidence intervals. A total of 283 HIV-positive adults on ART were included in the analysis. Females accounted for 66% of participants, and 63% were aged below 45 years. More than half of the participants had been on ART for over five years, and 98% were receiving a tenofovir–lamivudine–dolutegravir (TLD)-based regimen. None of the participants tested positive for HBsAg or anti-HCV antibodies. No cases of dual HBV/HCV infection were identified, yielding a seroprevalence of 0% for HBV, HCV, and HBV/HCV co-infection. No evidence of HBV or HCV co-infection was found among HIV-positive adults receiving ART in Kakonko District. Long-term ART use and effective HIV prevention and care interventions may have contributed to these findings. Continued routine hepatitis screening and integration of viral hepatitis services within HIV care programs are recommended to sustain low co-infection rates.

Fields of Study & Subjects

Hepatitis B Virus Studies Hepatitis C virus research HIV/AIDS Research and Interventions

Publication details

Journal / source
American Journal of Epidemiology and Infectious Disease
Volume
14
Issue
1
Pages
9–13
Publication date
25 March 2026
Language
EN